dihexa pnb-0408 c-met hgfr activator HGF/c-MET Signaling in Melanocytes and Melanoma Pancreatic Cancer Treatment Targeting the
Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology dihexa n hexanoyl tyr ile 6 aminohexanamide Dihexa 1401708 83 5 Dihexa;PNB 0408; N hexanoic Try Ile (6) amino hexanoic amide Activated HGF c Met Axis in Head and Neck Cancer dihexa hgf c met agonist Structural basis of the activation of c MET receptor
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




